UBE2E2 Gene - Ubiquitin Conjugating Enzyme E2 E2

Comprehensive biomedical resource for UBE2E2: genomic data, expression, mutations, and disease associations.

Gene Information Card

Symbol UBE2E2
Full Name Ubiquitin Conjugating Enzyme E2 E2
Gene Type protein-coding
Chromosomal Location 3p24.3
NCBI Gene ID 7325 ncbi.nlm.nih.gov/gene/7325
Ensembl ID ENSG00000170144
UniProt ID Q96LR5
OMIM ID 602999
HGNC ID 12478
Aliases UBE2E2, UBCH8, UbcM2, E2-25K

Description

UBE2E2 (Ubiquitin Conjugating Enzyme E2 E2) is a protein-coding gene that encodes a member of the ubiquitin-conjugating enzyme family. The encoded protein catalyzes the second step of ubiquitination, transferring ubiquitin from the E1 complex to a lysine residue on the target protein. UBE2E2 is involved in protein degradation, cell cycle regulation, and DNA repair. It is widely expressed in various tissues and has been implicated in several cancers and metabolic disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Type 2 Diabetes Impaired insulin signaling and beta-cell dysfunction; UBE2E2 variants associated with altered glucose homeostasis. GWAS (PMID: 24509480)
Breast Cancer Dysregulation of ubiquitin-proteasome pathway; UBE2E2 overexpression linked to poor prognosis. COSMIC (Catalogue of Somatic Mutations in Cancer)
Colorectal Cancer Altered ubiquitination of tumor suppressors; UBE2E2 mutations found in tumor samples. COSMIC (Catalogue of Somatic Mutations in Cancer)
Prostate Cancer Potential role in androgen receptor signaling; UBE2E2 expression changes in metastatic tissue. NCBI Gene (7325) - GeneCards

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 High
Thyroid 8.2 Medium
Adrenal Gland 7.1 Medium
Liver 6.8 Medium
Brain 5.3 Low
Heart 4.9 Low
Cell Line Expression
Cell Line nTPM Notes
HEK293 15.2 High expression in embryonic kidney cells
HeLa 11.8 Moderate expression in cervical cancer cells
MCF7 9.5 Moderate expression in breast cancer cells
HepG2 7.3 Low expression in liver cancer cells
K562 6.1 Low expression in leukemia cells
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.337C>T (p.Arg113Trp) Missense 0.0012 (gnomAD) Altered ubiquitin transfer activity; potential loss of function
c.454G>A (p.Glu152Lys) Missense 0.0008 (gnomAD) Reduced E2 enzyme activity; associated with type 2 diabetes risk
c.123_124insA (p.Glu42Argfs*19) Frameshift <0.0001 (COSMIC) Loss of function; truncation of catalytic domain
c.789C>T (p.Ser263=) Synonymous 0.0035 (gnomAD) No known functional effect; silent variant
Mutation functional classification

Loss of Function (LOF)

Frameshift and missense variants (e.g., p.Arg113Trp, p.Glu152Lys) reduce or abolish ubiquitin-conjugating activity, impairing protein degradation pathways.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in curated databases.

Dominant Negative (DN)

No evidence of dominant-negative effects in current literature or databases.

Pathways

• Ubiquitin mediated proteolysis (KEGG: hsa04120)
• Protein processing in endoplasmic reticulum (KEGG: hsa04141)
• Cell cycle (Reactome: R-HSA-1640170)

Protein Summary

The UBE2E2 protein (UniProt Q96LR5) is a 183-amino acid ubiquitin-conjugating enzyme (E2) with a conserved catalytic domain. It accepts ubiquitin from the E1 activating enzyme and transfers it to target proteins via an E3 ligase. UBE2E2 is involved in ubiquitin-dependent proteasomal degradation, cell cycle progression, and DNA repair. Its expression is highest in testis and thyroid, and it is implicated in type 2 diabetes and multiple cancers.

Related Products

Product name Cat.No. Species Gene ID
UBE2E2 Knockout HEK293 Cell Line EDJ-KQ5992 Human 7325 Details Get a Quote
UBE2E2 Knockout A-549 Cell Line EDJ-KQ29578 Human 7325 Details Get a Quote
UBE2E2 Knockout HCT 116 Cell Line EDJ-KQ29579 Human 7325 Details Get a Quote
UBE2E2 Knockout HeLa Cell Line EDJ-KQ29580 Human 7325 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: